Evidence map›Paper›PMID 31624734›Full record

ReviewAnnals of translational medicine2019

An evaluation of biomaterials and osteobiologics for arthrodesis achievement in spine surgery.

Joon S Yoo, Junyoung Ahn, Dillon S Patel, Nadia M Hrynewycz, Thomas S Brundage, Kern Singh

Abstract readReview
In one paragraph

Review in Annals of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Osteobiologics and Value-Based Care: Challenges and Opportunities.International journal of spine surgery · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Therapeutics for enhancement of spinal fusion: A mini review.Journal of orthopaedic translation · 2021
    Review
  12. Article
  13. Trends in lumbar spinal fusion-a literature review.Journal of spine surgery (Hong Kong) · 2020
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joon S YooDepartment of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA.
Junyoung AhnDepartment of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA.
Dillon S PatelDepartment of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA.
Nadia M HrynewyczDepartment of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA.
Thomas S BrundageDepartment of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA.
Kern SinghDepartment of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An increasing variety of orthobiologic materials, including autologous and allogeneic bone graft, bone marrow aspirate, demineralized bone matrix, ceramics, and growth factors are available to the spine surgeon. Although autologous bone graft remains the gold standard material, concerns for failure in achieving fusion have prompted evaluation of current and new biologic materials. As such, this review attempts to summarize the available biologic materials with their pertinent characteristics, advantages, disadvantages, and primary uses.

Indexed as

allograftautograftBiologicsbiomaterialsspine surgery

Identifiers

PMID31624734
PMCPMC6778273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.